The Effect of eIF4E Antisense RNA Expression on Prostate Tumor Angiogenesis and Growth

Abstract

We set out to investigate the role of the translation initiation factor elF4E in prostate cancer angiogenesis and to determine if suppression of elF4E could have clinical benefit. This is highly relevant to both early and late stages of prostate cancer, for tumor angiogenesis is critical to primary tumor growth, as well as metastasis. We found elevated elF4E levels in a significant number of prostate tumors where it cd-localized with both increased vascular endothelial growth factor (VEGF) and vessel density. We set up cell line models and saw that prostate cancer cells overexpressing elF4E had higher levels of secreted VEGF and grew faster than control cells when injected into mice, while prostate cancer cells expressing an elF4E anti-sense RNA (and thus with lower elF4E levels), had depressed VEGF levels and did not grow in the mouse model. Unlike other cell types, however, in prostate cells, elF4E expression was not associated with any change in the expression pattern of isoforms of FGF-2 or VEGF. In addition, elF4E expression did not appear to be correlated with p53 status, however, we are continuing to investigate whether levels of p53 protein may be in part regulated at the level of translation.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Mar 01, 2001
Accession Number
ADB274441

Entities

People

  • Briana J. Williams

Organizations

  • Louisiana State University

Tags

DTIC Thesaurus Topics

  • Abstracts
  • African Americans
  • Angiogenesis
  • Antisense Elements (Genetics)
  • Biomedical Research
  • Blood Vessels
  • Cancer
  • Cell Line
  • Cells
  • Cultured Cells
  • Governments
  • Growth Factors
  • Health Services
  • Microvessels
  • Modulation
  • Prostate Cancer
  • Translations

Fields of Study

  • Biology

Readers

  • Breast cancer cell signaling and growth regulation.
  • Molecular Genetics
  • Women's Health and Cancer Risk Research: African American Women and Pregnancy Outcomes.